New Pathways to Early Detection and Intervention in Alzheimer’s Disease

Saturday, May 30, 2026, at 10:00 a.m.

PROGRAM OVERVIEW

This series of caregiver communication virtual summit meetings is a dynamic satellite symposium designed to equip neurologists, primary care professionals (PCPs), geriatricians, psychiatrists, neuroradiologists, nurses, nurse practitioners (NPs), and physician assistants (PAs) with practical, evidence-based strategies to enhance the early identification and management of mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Faculty will present integrated approaches to screening, diagnosis, and staging that combine clinical evaluation with objective cognitive and biomarker testing, alongside current clinical practice recommendations for disease-modifying therapies (DMTs), including appropriate patient selection and the monitoring and management of adverse events such as amyloid-related imaging abnormalities (ARIA). A highlight of this summit is a live caregiver discussion, featuring an Alzheimer’s disease caregiver in conversation with a specialist, offering real-world insight into the patient and family experience and deepening understanding of effective caregiver communication. Emphasizing multidisciplinary collaboration and shared decision-making, the program supports clinicians in delivering timely, compassionate, and patient-centered care across the continuum of Alzheimer’s disease.

TARGET AUDIENCE

This activity is designed to meet the educational needs of neurologists, PCPs, geriatricians, psychiatrists, neuroradiologists, nurses, NPs, and PAs.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Implement evidence-based strategies for screening, diagnosing, and staging MCI and AD that integrate clinical assessment with objective cognitive and biomarker testing

• Apply the latest clinical practice recommendations for the use of DMTs for AD, including criteria for appropriate patient selection

• Develop strategies to identify, monitor, and manage adverse events associated with DMTs for AD, particularly ARIA

• Formulate best practices for a multidisciplinary approach that incorporates shared decision-making when discussing the treatment options and management of AD

Learn more and register here

From Message to Motivation: Communication Strategies That Drive Cancer Prevention Behaviors Webinar

Webinar Overview

Join the Roybal Center for Promoting Adherence to Behavior Change and Enhancing Cognitive Function for an upcoming webinar, June 3, 2026, at 11:00 am ET titled “From Message to Motivation: Communication Strategies That Drive Cancer Prevention Behaviors.” This webinar will feature Dr. William Calo and will explore how effective communication can influence health behaviors and support cancer prevention efforts.

Click here to register

A New Era for Alzheimer’s Treatment: Promise, Tradeoffs, & Tough Questions

April 30, 2026 | 3:-0AM – 4:30PM ET

A new generation of Alzheimer’s treatments is reshaping the landscape of dementia care. This webinar will examine what these drugs are, how they differ from previous therapies that primarily addressed symptoms, and what we know about their benefits and risks. Have these treatments changed patient care in meaningful ways? How are patients and families experiencing them in the real world? We will also explore pressing questions about affordability and access—particularly given that most people living with dementia rely on Medicare—and consider whether the clinical benefits observed to date justify the costs within a constrained health care system.

At the same time, advances in blood-based biomarkers now allow clinicians to detect Alzheimer’s-related brain changes before symptoms appear, raising complex ethical and clinical questions. How should this information be used, especially when many people with biomarker evidence may never develop dementia? The conversation will also address widespread claims about preventing cognitive decline—from coffee consumption to brain-training apps—separating evidence from hype. Finally, we will look ahead to the research frontier, highlighting the most promising scientific hypotheses and emerging approaches that could shape the next era of Alzheimer’s prevention and treatment.

Learn more and register here